The ascendancy of Viagra and its effect on the medicinal landscape presents a complex question for shareholders. While the initial sales statistics were impressive, the patent has ended, leading to a get more info wave of copycat alternatives that are chipping away at revenue. Moreover, the sector is facing issues related to aging trends and shifti